In a further study of nearly 33,000 cases of circulating free tumor DNA (cfDNA) from metastatic patients, RET fusion events were identified in NSCLC and in colorectal, breast, and thyroid carcinomas [121]. The gene discussed is RET; the disease is thyroid gland carcinoma.